We are specialists for advanced solutions in preclinical disease models and drug discovery.
The company has pioneered an unique portfolio of 3D tissue imaging and analysis assays all based on the innovative flexibility of our 3D CoSeedis™ Co-Culture System, enabling the easy and reliable generation of quantitative datasets from tissues and cells.
We offer a service that supports pharmaceutical and biotech companies to improve the predictiveness of their preclinical models and to accelerate their drug discovery efforts. Using our dedicated 3D CoSeedis™ cell culture technology we are reducing the translational gap between in vitro and in vivo studies through the use of a new level of differentiation and inter-cellular communication assays.
Since the foundation in 2018 we have worked with numerous clients to develop customised assays and/or enhancements of our 3D technology platform for the use in specific projects.
abc biopply offers a wide range of assay formats and downstream endpoints and also implements services for larger clients who wish to in-source our custom-built assays.
